Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA – Get Free Report) passed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $0.17 and traded as high as $0.22. Sonoma Pharmaceuticals shares last traded at $0.21, with a volume of 2,093,695 shares traded.
Sonoma Pharmaceuticals Price Performance
The firm has a market capitalization of $3.99 million, a PE ratio of -0.29 and a beta of 1.37. The stock’s 50-day moving average price is $0.18 and its 200 day moving average price is $0.17.
About Sonoma Pharmaceuticals
Sonoma Pharmaceuticals, Inc, develops and produces stabilized hypochlorous acid (HOCl) products for wound care, animal health care, eye care, oral care, and dermatological conditions in the United States, Latin America, Europe, Asia, and internationally. The company offers Regenacyn, a prescription scar gel; Pediacyn, a pediatric dermatology and wound care product for over-the-counter (OTC) use; Epicyn, an Antimicrobial Facial Cleanser; Levicyn, an HOCl based prescription and OTC product to use and relieve skin irritations, lacerations, abrasions, and burns; Celacyn, a scar management gel; and SebuDerm to manage and relieve the burning, itching, erythema, scaling, and pain associated with seborrhea and seborrheic dermatitis.
Featured Articles
- Five stocks we like better than Sonoma Pharmaceuticals
- What is a Bond Market Holiday? How to Invest and Trade
- BlackBerry Stock: Strong Earnings, Profitability Challenges Ahead
- Learn Technical Analysis Skills to Master the Stock Market
- Progress Software Stock Back in the Green After Beating Forecasts
- Basic Materials Stocks Investing
- Goldman Sachs Raises Stock Target for Affirm: Key Insights
Receive News & Ratings for Sonoma Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sonoma Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
